National Leiomyosarcoma Foundation

Analysis

National Leiomyosarcoma Foundation is a registered charity in United States, based in Denver, CO. It received its IRS tax-exemption ruling in August 2002, 24 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, National Leiomyosarcoma Foundation reported income of $258k and spending of $259k, spending 101% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $127k to $258k (+103%), an average of +19% a year. The sharpest change came in the year to December 2022, when income rose by 47%. Over the whole period it spent 74% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, National Leiomyosarcoma Foundation sits at the 45th percentile: it is larger than about 45% of them. Against every charity in United States with reported income it ranks in the 59th percentile, and in the 56th percentile within CO. Charities of a similar size with the same main cause include Socialization Independence Development Empowerment Inc ($258k), McGrorty Foundation Inc ($258k) and RX Compassion Inc ($258k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. At year end it held assets of $463k against liabilities of $0, net assets of $463k.